Abstract
In this chapter, we describe briefly the cancer genetics field. Basic notions of genetics and mode of inheritance will be summarized first, in order to introduce clinical cancer genetic assessment and, finally, genetic counseling that should go along with any genetic testing.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Paul Broca Traité des tumeurs, 1866.
Familial Cancer Prevalence Spanning Eight Years: Family N. Henry T. Lynch, MD. Arch Intern Med. 1974;134(5):931–938.
Nagy R, Sweet K, Eng C. Highly penetrant hereditary cancer syndromes. Oncogene. 2004;23:6445–70.
Biologie Moléculaire de la cellule, éditions DE BOECK.
Genes VI, éditions DE BOECK.
Chial et al. 2008.
American Cancer Society. www.cancer.org.
Antoniou AC, et al. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer. 2008;98:1457–66.
Chappuis PO, Bolliger B, Bürki N, Buser K, Heinimann K, Monnerat C, Morant R, Pagani O, Perey L, Rabaglio M, Sheila Unger on behalf of the Swiss Group for Clinical Cancer Research (SAKK) Network for Cancer Predisposition Testing and Counseling. Swiss guidelines for counseling and testing Genetic predisposition to breast and ovarian cancer; 2017.
Hall J, Lee M, Newman B, Morrow J, Anderson L, Huey B, King M. Linkage of early-onset familial breast cancer to chromosome 17q21. Science. 1990;250:1684–9.
Strattot M. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995;378(6559):789–92.
Kuchenbaecker KB, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317:2402.
Ashworth A. A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair. JCO. 2008;26:3785.
Hall MJ, et al. Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond. Gynecol Oncol. 2016;140:565.
Robson ME, et al. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol. 2015;33:3660.
Hall MJ, Forman AD, Pilarski R, Wiesner G, Giri VN. Gene panel testing for inherited cancer risk. J Natl Compr Canc Netw. 2014;12:1339.
Richards S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405.
Van El CG, et al. Whole-genome sequencing in health care. Recommendations of the European Society of Human Genetics. Eur J Hum Genet. 2013;21:580–4.
Ayme S, Gribaldo L, Matthijs G, Borry P. European workshop on genetic testing offer in Europe; 2013. https://doi.org/10.2788/77188.
Kalia SS, et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SFv2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med. 2017;19(2):249–255. https://doi.org/10.1038/gim.2016.190.
Farmer H, McGabe N, Lord CJ, et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature. 2005.
Bryant HE, Schultz N, Thomas HD, et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymérase. Nature. 2005.
Fong PC, Boss DS, Yap TA, et al. Inhibition of poly (ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med. 2009.
Audeh W, Carmichael J, Penson RT, et al. Oral poly (ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial. Lancet. 2010.
O’Shaughnessy J, Osborne C, Pippen JE, et al. Iniparib plus chemotherapy in metastatic triple-negative breast cancer. N Engl J Med. 2011;364(3):205–14.
Foster C, Watson M, Eeles R, Eccles D, Ashley S, Davidson R, … Psychosocial Study Collaborators 11. Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-up. Br J Cancer. 2007;96(5):718–24. https://doi.org/10.1038/sj.bjc.6603610.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Met-Domestici, M., Murphy, A.E. (2019). Genetic Counseling. In: Charnay-Sonnek, F., Murphy, A. (eds) Principle of Nursing in Oncology . Principles of Specialty Nursing. Springer, Cham. https://doi.org/10.1007/978-3-319-76457-3_25
Download citation
DOI: https://doi.org/10.1007/978-3-319-76457-3_25
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-76456-6
Online ISBN: 978-3-319-76457-3
eBook Packages: MedicineMedicine (R0)